Teva Pharmaceutical Industries Ltd.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Vaccines

Other Names/Subsidiaries

  • ABIC Marketing Limited
  • AbZ-Pharma
  • Auspex Pharmaceuticals, Inc. (Imphar AG)
  • Barr Pharmaceuticals
  • Bentley Pharmaceuticals
  • BioGeneriX AG
  • BioAssets Development Corporation
  • Cephalon, Inc. (Arana Therapeutics (Peptech and EvoGenix)
  • Ception Therapeutics
  • ChemGenex Pharmaceuticals Limited
  • CIMA Labs
  • Gemin X Pharmaceuticals
  • CT\r\nArzneimittel GmbH
  • Gecko Health Innovations
  • IVAX Corporation
  • Labrys Biologics
  • Mepha
  • MicroDose Therapeutx Inc.
  • Neose Technologies, Inc.
  • NuPathe, Inc.
  • PLIVA HRVATSKA d.o.o.
  • ratiopharm Group
  • Sicor Biotech
  • Representaciones e Investigaciones Médicas, S.A. de C.V.
  • Taiyo Pharmaceutical Industry Co. Ltd.
  • Teva Branded Pharmaceutical Products, R&D Inc.
  • Teva Women's Health, Inc.
  • Actavis Generics
  • Anda, Inc.
  • Uteron Pharma S.P.R.L.
  • Teva Takeda Yakuhin Ltd.
  • Teva Takeda Pharma Ltd.
  • Teva Neuroscience, Inc.
  • Teva Pharmaceuticals USA, Inc.
  • Zeneus Pharma
  • CT Arzneimittel
  • Abic
  • Approved Prescription Services
  • Auspex Pharmaceuticals
  • Biocraft
  • Biogal Pharmaceutical Works
  • Cephalon
  • CoGenesys
  • Copley Pharmaceutical
  • Corporación Infarmasa
  • IVAX
  • Kunming Baker Norton Pharmaceuticals
  • Laboratorios Rimsa
  • Novopharm
  • NuPathe
  • Pharmachemie
  • PLIVA
  • Odyssey Pharmaceuticals
  • Sidmak Laboratories
  • Taisho Pharmaceutical Industries
  • Teva Neuroscience
  • Tianjin Hualida Biotechnology
  • AbZ Pharma
See more in Biomedtracker

Latest on Teva Pharmaceutical Industries Ltd.

Generics Bulletin

Teva’s Ratiopharm Bags Rights In Germany To Formycon’s Stelara Biosimilar

 
• By Dean Rudge

Formycon is “convinced that we can significantly increase market coverage in Germany” for its biosimilar to Stelara (ustekinumab), after entering into a distribution agreement with Teva’s Ratiopharm s

Pink Sheet

EMA Nod For First MASH Drug Rezdiffra, Cell Therapy Zemcelpro And 11 Others

 
• By Eliza Slawther

Thirteen medicines were backed for pan-EU marketing authorizations this week by the European Medicines Agency’s human medicines committee, the CHMP, including Madrigal Pharmaceuticals’ Rezdiffra (resm

Scrip

Asia Deal Watch: SunRock, Escugen Collaborate On CCR9-Targeted ADC

 
• By Joseph Haas, Lisa Takagi, Sushmita Panda, and Xu Hu

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. SunRock, Escugen Partner To Develo

Generics Bulletin

Teva Continues Push Beyond Generics in Fosun Immunotherapy Tie-Up

 
• By Dean Rudge

Teva and China’s Shanghai Fosun Pharmaceutical have welcomed a significant step forward in the global development of Teva’s novel immunocytokine fusion protein candidate TEV-56278, striking a strategi